ClinicalTrials.Veeva

Menu

The Effect of Sugammadex Given Based on Ideal, Actual or Adjusted Body Weight on Reversal of Rocuronium.

A

Ain Shams University

Status

Completed

Conditions

Muscle Relaxation

Treatments

Drug: Sugammadex

Study type

Interventional

Funder types

Other

Identifiers

NCT03381209
FMASU R 39/2017

Details and patient eligibility

About

The aim of this study is compare the reversal of rocuronium induced neuromuscular blockade in morbidly obese patients using three doses of sugammadex; based on ideal body weight, adjusted body weight, and actual body weight.

Full description

The aim of this study is compare the reversal of rocuronium induced neuromuscular blockade in morbidly obese patients using three doses of sugammadex; based on ideal body weight, adjusted body weight, and actual body weight. Reversal Time: time from administration of Sugammadex to train of four (TOF) ratio ≥ 0.9 will be used as primary outcome.

Time need for extubation (time from administration of sugammadex to extubation), and duration of stay in post anesthesia care unit (PACU), will be used as secondary outcome.

Enrollment

60 patients

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients older than 18 years and under 45 years,
  • body mass index ≥ 40 kg/m2, with indication of bariatric surgery

Exclusion criteria

  • Patients with comorbid including: neuromuscular disease, renal impairment, and patients with difficult airway were excluded from this study.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 3 patient groups

Group A
Experimental group
Description:
Sugammadex given in a dose of 2mg/kg based on ideal body weight
Treatment:
Drug: Sugammadex
Group B
Experimental group
Description:
Sugammadex given in a dose of 2mg/kg based on adjusted body weight
Treatment:
Drug: Sugammadex
Group C
Experimental group
Description:
Sugammadex given in a dose of 2mg/kg based on actual body weight
Treatment:
Drug: Sugammadex

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems